You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucagon-Like Peptide-1 (GLP-1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Retrospective Data of Glucagon-like Peptide-1 Participanta With

Recruiting
  • Diabetes Mellitus, Type 2
  • Skopje, North Macedonia
    Novo Nordisk Investigational Site
Jul 22, 2022

s and Activity Data in Type 2 Diabetes on Different Treatments

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Lifestyle
  • +4 more
  • (no location specified)
Sep 16, 2022

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)

Completed
  • Type 2 Diabetes
  • Obesity
  • Roux-en-Y
  • +4 more
  • Turku, Finland
    Turku univercity hospital, PET center
Oct 12, 2021

Type 2 Diabetes in Obese Trial in Derby (Semaglutide Pen Injector [Ozempic], Very-low Calorie Diet)

Recruiting
  • Type 2 Diabetes Mellitus in Obese
  • Semaglutide Pen Injector [Ozempic]
  • Very-low Calorie Diet
  • Derby, United Kingdom
    University of Nottingham, Royal Derby Hospital Centre
Oct 31, 2022

Cardiovascular Diseases Trial in Cambridge (Saline 0.9%, Glucagon (25ng/kg/min), Glucagon (50ng/kg/min))

Recruiting
  • Cardiovascular Diseases
  • Saline 0.9%
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Dec 10, 2021

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Glucagon-Like Peptide-1 Receptor, Metformin, Obesity, Abdominal Trial in Shanghai (Liraglutide, Semaglutide, Metformin)

Recruiting
  • Glucagon-Like Peptide-1 Receptor
  • +7 more
  • Shanghai, Shanghai, China
    Ren Ji Hospital, Shanghai Jiao Tong University School of Medicin
Mar 9, 2023

Anti-obesity Pharmacotherapy and Inflammation

Not yet recruiting
  • Obesity
  • Liraglutide or Semaglutide
  • Phentermine-Topiramate combination
  • New Orleans, Louisiana
  • +1 more
Mar 3, 2023

Obesity Trial in Brisbane (XW003, Saxenda)

Recruiting
  • Obesity
  • Brisbane, Queensland, Australia
    Paratus Clinical Research Brisbane
Dec 6, 2021

Chronic Kidney Diseases Trial in Nashville (dulaglutide injection)

Recruiting
  • Chronic Kidney Diseases
  • dulaglutide injection
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 20, 2022

Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA

Recruiting
  • Severe Obesity
  • Type 2 Diabetes Mellitus in Obese
  • Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
  • São Paulo, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022

Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,

Recruiting
  • Idiopathic Intracranial Hypertension
  • +5 more
  • Glostrup, Denmark
  • +1 more
Sep 7, 2023